Standards & Regulation

How can companies avoid the risks of HPAPI containment and handling?

Power testing partnership, NASH breakthrough designation, and new CEO appointments. What’s new for pharma in business?

Sitting Down With... Kimberly Eggers, Vice-president of Medical and Clinical Affairs at Aprecia.

How is African pharma coping with the COVID-19 pandemic?

Can the African Medicines Agency be mobilized quickly enough to respond to the needs of the pharmaceutical sector?

How will new guidance issued by the FDA affect drug importation?

Amgen developed the Multi-Attribute Method (MAM) to obtain high-fidelity understanding of the quality of its own biologics. Click to read article

Amgen has brought the Multi-Attribute Method (MAM) into the mainstream, but what’s next for this analytical workflow. Click to read article

The UK’s medicines regulator releases new guidance for Brexit.

When it comes to using AI in drug development, companies need to consider how they create and protect their intellectual property.